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Intraductal/intracystic papillary carcinoma (IPC) of the breast is defined as a malignant 
non-invasive papillary tumor arising from the ductal-lobular system. Based on the 
presence of myoepithelial cells in the cystic wall, IPC is distinguished from 
encapsulated papillary carcinoma (EPC). Here, we report a case of an intracystic 
apocrine papillary tumor in the breast of a 49-year-old woman. Histopathologic 
examination revealed that the entire papillary structures and cyst wall were comprised 
of apocrine cells, some of which showed nuclear atypia with macronucleoli. 
Immunohistochemical examination revealed a lack of myoepithelial cells in the 
papillary fronds and cyst wall. Although the dense proliferation of apocrine cells 
mimicked a cribriform pattern, detailed examination identified a delicately intermingled 
interstitium in the cribriform-like growth area in the present case. Only a few apocrine 
variants of IPC or EPC have been reported to be malignant or potentially malignant. 
Since even benign apocrine lesions are known to lack myoepithelial cells, 
histopathologic evaluation regarding malignant potential requires caution in apocrine 
variants. 
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Intracystic/intraductal papillary carcinoma (IPC) of the breast is defined as a 
malignant non-invasive neoplastic epithelial proliferation with a papillary architecture 
in the lumen of the ductal-lobular system in the WHO classification published in 2012 
[4]. Histologically, the tumor shows slender fronds with absent or scant myoepithelial 
cells and epithelial cells, which all have architectural and cytological features of ductal 
carcinoma in situ [4]. Encapsulated papillary carcinoma (EPC) is a variant of papillary 
carcinoma, which is surrounded by a thick fibrous capsule. IPC has myoepithelial cells 
in the cyst wall and is clearly distinguished from EPC. 
A few cases of apocrine variants of IPC or EPC have been reported to date [2,3,7]. 
Owing to the limited cases with short-term follow-up periods, their malignant potential 
has been inconclusive. Furthermore, histologic evaluation of malignancy is potentially 
difficult, particularly in low-grade tumors, because even non-neoplastic apocrine lesions 
may lack myoepithelial cells [2,8]. 
Here, we describe a case of an intracystic atypical apocrine papillary tumor 
simulating IPC, but with complete absence of myoepithelial cells in the cyst wall, and 
discuss the current issues regarding the malignant potential of IPC and/or EPC. 
Case report 
A 49-year-old woman was referred to our hospital after an abnormality was 
detected on a mammographic examination. Sonography showed a cystic mass 
measuring 2 cm in the subareolar region of her left breast. Two weeks later, the mass 
had enlarged to 7×4×4 cm in size, and contained some subcentimetric mural nodules. 




Grossly, the translucent cyst had a smooth inner surface and included three 
papillary yellow nodules measuring 1.0, 0.9, and 0.3 cm in diameter, respectively. 
Cytologically, the cyst contents included some three-dimensional papillary 
clusters in a background of scattered foamy macrophages (Fig. 1A). The cells of these 
clusters had relatively rich cytoplasm, large nuclei, and prominent macronucleoli. On 
the other hand, some clusters also included cells with abundant and granular cytoplasm, 
which were identical to benign apocrine cells (Fig. 1B). The cells were generally 
cohesive and the borders of the cell membranes were distinct. These findings suggested 
intracystic apocrine neoplasia, but were inconclusive for malignancy. 
Histologically, epithelial papillary lesions were present in the cystically dilated 
duct (Fig. 2A). Branching fibrovascular stalks were relatively broad with occasional 
edematous areas, and were covered by cells with abundant eosinophilic granular to pale 
cytoplasm (Fig. 2B). No myoepithelial cells were found. The nuclei were prominent 
with distinctive nucleoli (Fig. 2C). Although cribriform-like patterns were observed 
focally (Fig. 2D and E), more detailed examination revealed the presence of a delicate 
interstitium between glands (Fig. 2E). We confirmed that each gland was surrounded by 
type IV collagen immunohistochemically (Fig. 2F). Mitotic figures were sparsely 
observed (Fig. 2G). The cyst wall was covered with atrophic apocrine epithelium (Fig. 
2H). 
In an immunohistochemical study, the tumor cells showed diffuse and strong 
cytoplasmic positivity for 15-kDa glycoprotein of gross cystic disease (GCDFP-15). 
Myoepithelial markers such as p63 (Fig. 2I), calponin, and CD10 were negative in both 
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the papillary nodules and cyst wall. High molecular weight cytokeratins (HMWCs) such 
as CK5/6 (Fig. 2J) and 34βE12 were also negative in the nodules. Androgen receptor 
was entirely positive (Fig. 2K), while estrogen receptor, progesterone receptor, and 
Her-2 were completely negative. Proliferative activity measured with Ki-67 was less 
than 1%. 
Discussion 
An intracystic/intraductal papillary tumor composed of an entirely apocrine 
epithelium is rare. Seal et al. [7] reported five cases with this lesion as encapsulated 
apocrine papillary carcinoma for the first time. According to their descriptions, all of 
their cases showed varied complexity of apocrine cell proliferation and had 
pseudopapillary and/or cribriform architectures. The cytological atypia were also varied 
in their cases. They described that it was not yet known whether this lesion is a form of 
papillary hyperplasia of apocrine cells or a true neoplasm [7]. 
Laforga et al. [3] reported a case with an apocrine type of EPC, and described that 
their case showed features fitting with low-grade carcinoma according to the criteria of 
O’Malley and Bane [6], such as cell size, atypical nuclei with macronucleoli, 
architecture showing papillary and cribriform patterns of growth, and so on. 
Cserni [2] reported a case of intracystic papillary apocrine proliferation. He 
mentioned the difficulty associated with determination of malignancy because of the 
short-term follow-up, but supported benign biologic behavior. 
One of the most challenging issues is to assess apocrine atypia, and mainly 
differentiate between atypical apocrine proliferations and low-grade apocrine ductal 
carcinoma in situ (DCIS). O’Malley et al. [6] summarized the criteria that have been 
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proposed thus far. Atypical apocrine lesions show three-fold nuclear enlargement with 
nucleolar enlargement, slightly irregular nuclear membranes, and fine chromatin. 
Nuclear stratification or tufting of the epithelium may be present in atypical apocrine 
lesions. Low-grade DCIS shows irregular nuclear membranes and coarse chromatin, and 
may exhibit a characteristic cribriform architecture. However, there are no broadly 
accepted criteria for distinguishing these lesions to date. 
For the differentiation, it may be difficult to use elements such as irregular 
nuclear membranes or coarse chromatin because a ―borderline‖ apocrine lesion shows 
―borderline‖ nuclear atypia. These nuclear findings are relatively vague and 
noncommittal, especially for cases in which pathologists are irresolute. Among the 
criteria summarized by O’Malley et al. [6], the cribriform architecture might be a 
relatively identifiable feature because of its distinct pattern. 
In the present case, the apocrine papillary epithelium revealed relatively uniform 
nuclei with nucleolar enlargement, smooth nuclear membranes, and fine chromatin. 
Architecturally, an indistinct cribriform pattern was seen in part of the lesion. 
Coincident with this area, some atypical features such as rough chromatin and increased 
nuclear-cytoplasmic ratio were discernible. These findings might suggest malignant 
potential for this lesion. At first sight, this area appeared to be a ―true‖ cribriform 
pattern with punched-out regular spaces. However, as a result of more detailed 
observations, an interstitium intervened delicately among the glands and there was no 
solid growth pattern. We therefore judged it not to be a ―true‖ cribriform architecture, 
but a tubular architecture. 
Although a lack of myoepithelial markers is commonly used as a hallmark for 
papillary carcinoma, it has reported that apocrine lesions, either benign or malignant, 
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can show reduction and occasional complete loss of myoepithelial cells [1,8]. Tramm et 
al. [8] described that a malignant diagnosis with apocrine changes of the breast cannot 
yet solely rely on the presence or absence of myoepithelial cells, and should be based on 
the overall morphology, i.e., the cytologic and architectural features. 
HMWCs such as 34βE12 and CK5/6 are widely used for distinguishing benign 
proliferative lesions from DCIS, since the former characteristically show a mosaic 
pattern and the latter is negative for these antigens [5]. However, these antibodies are 
often useless for apocrine proliferative lesions because an apocrine metaplastic 
epithelium is included within ―false-negative‖ groups [5]. These peculiar 
immunohistochemical panels of the apocrine epithelium make the diagnosis of 
―borderline‖ lesions more difficult. The present case also showed complete negativity 
for myoepithelial markers and HMWCs. 
In summary, an intracystic papillary tumor composed of an entirely apocrine 
epithelium is rare. Although its monotonous appearance and florid growth might 
confuse pathologists, there are no distinct criteria to distinguish an atypical apocrine 
lesion from low-grade apocrine DCIS to date. Moreover, immunohistochemical panels 
such as myoepithelial markers and HMWCs may not be helpful for the diagnosis of this 
lesion. An apocrine epithelium has a broad cytoplasm and therefore its relatively dense 
proliferation mimics solid growth or a cribriform architecture. Consequently, 
pathologists should be cautious in the evaluation of malignancy for apocrine variants of 
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Fig. 1 Cytology of the contents of the cyst (Papanicolaou 400×): (A) Three-dimensional 
papillary cluster of cells with relatively rich cytoplasm, large nuclei, and prominent 
macronucleoli. (B) Some clusters had a sheet-like appearance, and were composed of 
obvious benign apocrine cells with abundant and granular cytoplasm. 
Fig. 2 Histological features: (A) Papillary nodule in a cystically dilated duct (H&E 20×). 
(B) Papillary architecture with an edematous stalk lined by apocrine cells (H&E 200×). 
(C) Relatively monotonous cells with abundant, eosinophilic, and granular cytoplasm 
(H&E 400×). (D) Focal cribriform-like architecture (H&E 100×). (E) High 
magnification of a cribriform-like portion showing a tubular pattern with intervention of 
a delicate interstitium (H&E 400×). (F) Type IV collagen surrounded each gland (400×). 
(G) Scattered mitoses were discernible (H&E 400×). (H) Atrophic apocrine cells lined 
the cyst wall (H&E 400×). (I) Both papillary nodules and the cyst wall had no cells 
positive for p63 (100×). (J) Proliferative cells were entirely negative for CK5/6 (100×). 
(K) Strong and diffuse immunoreactivity for androgen receptor (200×). 
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